TP53 and neoplasm: Indeed, a recent transcriptomic analysis of 10,817 tumor aliquots of over 30 tumor types from The Cancer Genome Atlas identified mutations in TP53 as a predictor of an increased tumor-infiltrating leukocyte fraction, particularly interferon-γ dominant subtypes and a Th2 cell bias to the adaptive immune infiltrate [116].